Personalizing Treatment Strategies Based on Multiple Myeloma Patient Genetics at Diagnosis: The objective of this study is to assess bone marrow biopsy slides obtained during your initial diagnosis of multiple myeloma and then define biological subtypes (DNA, RNA, protein, and other types of assays for tumor and none-tumor), predict prognosis, and potentially guide treatment decisions in the future, and anticipate the clinical outcomes associated with various myeloma treatment options and treatment combinations available to patients with multiple myeloma. This study is open to all myeloma patients regardless of where they are being treated. Patients only need to sign a consent form and connect their medical records, which takes less than 5 minutes. To learn more, click here: https://healthtree.org/myeloma/curehub/private/research/tvtF4ehxp6Kj233pQMFE